Protocol No.: INCA-34176-357

A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Principal Investigator
Shultz, Carl
Phase
III
Age Group
Adult
Applicable Disease Sites
Leukemia
Lymphoma
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kathryn Oliverio, LPN
Research Specialist
Phone: +1 304-293-7374

View on ClinicalTrials.gov